Literature DB >> 16534646

Cerebrospinal fluid shunt infection: risk factors and long-term follow-up.

Matthieu Vinchon1, Patrick Dhellemmes.   

Abstract

INTRODUCTION: Shunt infection (SI) is an enduring problem in pediatric neurosurgery. Its occurrence is variable in the different series that were published, according to the definition retained. In addition, long-term data, which could help to evaluate the incidence of delayed SI, as well as the developmental outcome after SI, are scarce in the literature.
MATERIALS AND METHODS: We reviewed retrospectively children shunted for hydrocephalus during the last 20 years to evaluate the incidence of SI, including late SI, the risk factors and sources of contamination, and the late outcome after SI.
RESULTS: We treated 1,173 patients who were followed-up for a mean duration of 7.0 years. During that period, 158 patients presented with a total number of 190 episodes of infection, 19 of which occurred more than 1 year after surgery. The infection rates per patient and per procedure were 13.6 and 5.9%, respectively. Age below 4 months at shunt insertion [odds ratio (OR)=1.81], antenatal diagnosis (OR=2.23), myelomeningocele (OR=2.14), and post-hemorrhagic hydrocephalus (OR=1.98) were significantly correlated with SI. SI was mostly due to intraoperative contamination; however, delayed SI was mostly caused by blood-borne contamination and abdominal sepsis. The mortality related to SI was 10.1%; the Glasgow Outcome Score, as well as schooling, was significantly and independently affected by SI.
CONCLUSION: Long-term follow-up of shunted children is necessary to evaluate the real incidence of SI and the functional outcome after SI.

Entities:  

Mesh:

Year:  2006        PMID: 16534646     DOI: 10.1007/s00381-005-0037-8

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  20 in total

1.  Late shunt infection: incidence, pathogenesis, and therapeutic implications.

Authors:  M Vinchon; M-P Lemaitre; L Vallée; P Dhellemmes
Journal:  Neuropediatrics       Date:  2002-08       Impact factor: 1.947

2.  Treatment of cerebrospinal fluid shunt infections: a decision analysis.

Authors:  Rachel T Schreffler; Andrew J Schreffler; Robert R Wittler
Journal:  Pediatr Infect Dis J       Date:  2002-07       Impact factor: 2.129

3.  Late shunt infections.

Authors:  C Baird; D O'Connor; T Pittman
Journal:  Pediatr Neurosurg       Date:  1999-11       Impact factor: 1.162

Review 4.  Cerebrospinal fluid shunt infections. Report of 41 cases and a critical review of the literature.

Authors:  M R Quigley; D H Reigel; R Kortyna
Journal:  Pediatr Neurosci       Date:  1989

5.  Factors causing acute shunt infection. Computer analysis of 1174 operations.

Authors:  D Renier; J Lacombe; A Pierre-Kahn; C Sainte-Rose; J F Hirsch
Journal:  J Neurosurg       Date:  1984-12       Impact factor: 5.115

6.  Cerebrospinal fluid shunt infection: a prospective study of risk factors.

Authors:  A V Kulkarni; J M Drake; M Lamberti-Pasculli
Journal:  J Neurosurg       Date:  2001-02       Impact factor: 5.115

7.  Infection of cerebrospinal fluid shunts in infants: a study of etiological factors.

Authors:  I K Pople; R Bayston; R D Hayward
Journal:  J Neurosurg       Date:  1992-07       Impact factor: 5.115

8.  Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus.

Authors:  Soma T Govender; Narendra Nathoo; James R van Dellen
Journal:  J Neurosurg       Date:  2003-11       Impact factor: 5.115

9.  Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens.

Authors:  Matthew J McGirt; Aimee Zaas; Herbert E Fuchs; Timothy M George; Keith Kaye; Daniel J Sexton
Journal:  Clin Infect Dis       Date:  2003-03-18       Impact factor: 9.079

View more
  49 in total

Review 1.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  Factors affecting infection development after meningomyelocele repair in newborns and the efficacy of antibiotic prophylaxis.

Authors:  Nihat Demir; Erdal Peker; İsmail Gülşen; Kemal Ağengin; Oğuz Tuncer
Journal:  Childs Nerv Syst       Date:  2015-04-14       Impact factor: 1.475

Review 3.  Ventricular shunt infections: immunopathogenesis and clinical management.

Authors:  Yenis Gutierrez-Murgas; Jessica N Snowden
Journal:  J Neuroimmunol       Date:  2014-08-13       Impact factor: 3.478

4.  Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts.

Authors:  Scott L Parker; Frank J Attenello; Daniel M Sciubba; Giannina L Garces-Ambrossi; Edward Ahn; Jon Weingart; Benjamin Carson; George I Jallo
Journal:  Childs Nerv Syst       Date:  2008-11-05       Impact factor: 1.475

5.  Predicting ventriculoperitoneal shunt infection in children with hydrocephalus using artificial neural network.

Authors:  Zohreh Habibi; Abolhasan Ertiaei; Mohammad Sadegh Nikdad; Atefeh Sadat Mirmohseni; Mohsen Afarideh; Vahid Heidari; Hooshang Saberi; Abdolreza Sheikh Rezaei; Farideh Nejat
Journal:  Childs Nerv Syst       Date:  2016-09-14       Impact factor: 1.475

6.  A retrospective study of infections after primary VP shunt placement in the newborn with myelomeningocele without prophylactic antibiotics.

Authors:  Dorte Clemmensen; Mikkel M Rasmussen; Claus Mosdal
Journal:  Childs Nerv Syst       Date:  2010-03-11       Impact factor: 1.475

7.  Few Patient, Treatment, and Diagnostic or Microbiological Factors, Except Complications and Intermittent Negative Cerebrospinal Fluid (CSF) Cultures During First CSF Shunt Infection, Are Associated With Reinfection.

Authors:  Tamara D Simon; Nicole Mayer-Hamblett; Kathryn B Whitlock; Marcie Langley; John R W Kestle; Jay Riva-Cambrin; Margaret Rosenfeld; Emily A Thorell
Journal:  J Pediatric Infect Dis Soc       Date:  2013-08-26       Impact factor: 3.164

8.  Reinfection after treatment of first cerebrospinal fluid shunt infection: a prospective observational cohort study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy E Gove; Nicole Mayer-Hamblett; Samuel R Browd; D Douglas Cochrane; Richard Holubkov; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; W Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; John R W Kestle
Journal:  J Neurosurg Pediatr       Date:  2018-02-02       Impact factor: 2.375

9.  Evaluation of an in vivo model for ventricular shunt infection: a pilot study using a novel antimicrobial-loaded polymer.

Authors:  Rajiv R Iyer; Noah Gorelick; Karen Carroll; Ari M Blitz; Sarah Beck; Caroline M Garrett; Audrey Monroe; Betty Tyler; Sean T Zuckerman; Jeffrey R Capadona; Horst A von Recum; Mark G Luciano
Journal:  J Neurosurg       Date:  2018-08-03       Impact factor: 5.115

10.  Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy Gove; Samuel R Browd; Richard Holubkov; John R W Kestle; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; Nicole Mayer-Hamblett
Journal:  J Pediatr       Date:  2016-09-28       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.